Akebia Therapeutics Resubmits NDA For Vadadustat To FDA

RTTNews | 726 days ago
Akebia Therapeutics Resubmits NDA For Vadadustat To FDA

(RTTNews) - Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for vadadustat for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.

Vadadustat, Akebia's investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is currently approved for use in 35 countries.

Based on standard NDA resubmission review timelines, a letter from the FDA acknowledging that the resubmission is complete, classifying the resubmission, and setting the PDUFA date is expected in 30 days. Akebia expects the FDA to set a PDUFA date of six months from the date of submission.

For More Such Health News, visit rttnews.com

read more
Akebia Therapeutics Expects To Resubmit NDA For Vadadustat NDA In Q3

Akebia Therapeutics Expects To Resubmit NDA For Vadadustat NDA In Q3

Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday that the company expects to resubmit its New Drug Application (NDA) for vadadustat as a treatment for anemia due to chronic kidney disease in adult patients on dialysis by the end of the third quarter of 2023.
RTTNews | 761 days ago
Australian Market Doubles Early Losses In Mid-market

Australian Market Doubles Early Losses In Mid-market

The Australian stock market is doubling its early losses in mid-market moves on Wednesday, snapping a three-session winning streak, with the benchmark S&P/ASX 200 falling below the 8,800 level, following the broadly negative cues from Wall Street overnight, with weakness in gold miners, financial and technology stocks partially offset by gains in iron ore miners and energy stocks.
RTTNews | 1h 14min ago
Asian Markets Track Wall Street Lower

Asian Markets Track Wall Street Lower

Asian stock markets are mostly lower on Wednesday, following the negative cues from Wall Street overnight, amid rising ambiguity over the outlook for interest rates after US Fed Chair Jerome Powell gave little indication about the future path of interest rates. Renewed trade tensions with the United States and the escalating tensions in Europe and the Middle East are weighing on market sentiment.
RTTNews | 1h 31min ago
Losing Streak May Continue For Thai Stock Market

Losing Streak May Continue For Thai Stock Market

The Thai stock market has moved lower in five straight sessions, shedding more than 35 points or 2.6 percent along the way. The Stock Exchange of Thailand now sits just above the 1,270-point plateau and it may take further damage again on Wednesday.
RTTNews | 2h 39min ago
Japanese Market Modestly Lower

Japanese Market Modestly Lower

The Japanese stock market is modestly lower in post-holiday trading on Wednesday, reversing some of the gains in the previous session, following the broadly negative cues from Wall Street overnight. The Nikkei 225 is falling below the 45,450 level, with a lack of direction leading to a mixed performance across most sectors.
RTTNews | 3h 4min ago
Indonesia Stock Market May Be Stuck In Neutral On Wednesday

Indonesia Stock Market May Be Stuck In Neutral On Wednesday

The Indonesia stock market has alternated between positive and negative finishes through the last four trading days since the end of the seven-day winning streak in which it had surged almost 400 points or 5 percent. Now at a fresh record closing high, the Jakarta Composite Index sits just above the 8,125-point plateau although it's due for profit taking on Wednesday.
RTTNews | 3h 9min ago
Lower Open Expected For Hong Kong Stock Market

Lower Open Expected For Hong Kong Stock Market

The Hong Kong stock market has finished lower in two straight sessions, shedding almost 400 points or 1.7 percent along the way. The Hang Seng Index now sits just beneath the 26,160-point plateau and it's tipped open under pressure again on Wednesday.
RTTNews | 3h 24min ago